Biodelivery Sciences International Inc Sample Contracts

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • February 10th, 2014 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York

This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of February 7, 2014, between BioDelivery Sciences International, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

AutoNDA by SimpleDocs
AND
Merger Agreement • August 12th, 2004 • Biodelivery Sciences International Inc • Pharmaceutical preparations • Delaware
EXHIBIT 10.1 LIMITED LIABILITY COMPANY OPERATING AGREEMENT
Operating Agreement • February 26th, 2003 • Biodelivery Sciences International Inc • Blank checks • Delaware
FORM OF
Underwriting Agreement • May 23rd, 2002 • Biodelivery Sciences International Inc • Blank checks • New York
Agreement
Agreement • February 1st, 2002 • Biodelivery Sciences International Inc • Blank checks
INTRODUCTION
Contribution Agreement • January 25th, 2001 • Biodelivery Sciences International Inc • Blank checks
BIODELIVERY SCIENCES INTERNATIONAL, INC. 12,000,000 Shares of Common Stock (par value $0.001 per share) Underwriting Agreement
Underwriting Agreement • April 11th, 2019 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York

BioDelivery Sciences International, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 10,000,000 shares of its common stock, par value $0.001 per share (the “Shares”), and Broadfin Healthcare Master Fund, Ltd. (the “Selling Shareholder”), proposes to sell to the Underwriters an aggregate of 2,000,000 Shares. The 10,000,000 Shares to be issued and sold by the Company and the 2,000,000 Shares to be sold by the Selling Shareholder are collectively referred to herein as the “Firm Shares.” In addition, the Selling Shareholder proposes to sell to the Underwriters, subject to the terms and conditions stated herein, up to an additional 1,800,000 Shares (the “Option Shares”), if and to the extent that the Representatives (as defined below) shall have determined to exercise, on behalf of the Underwriters, the right to purchase such Option Shares granted to the Underwriters in Section 3 her

Sales Agreement
Sales Agreement • July 2nd, 2015 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York

BioDelivery Sciences International, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • April 20th, 2010 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 20, 2010, is by and among BioDelivery Sciences International, Inc., a Delaware corporation with offices located at 801 Corporate Center Drive, Suite #210, Raleigh, NC 27607 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).

OF
Limited Liability Company Operating Agreement • November 19th, 2003 • Biodelivery Sciences International Inc • Pharmaceutical preparations • Delaware
AGREEMENT
Option Agreement • April 29th, 2002 • Biodelivery Sciences International Inc • Blank checks • Florida
1 2 by University. Said lease shall be for a period of five (5) years commencing on April 1, 2001.
Research Agreement • August 20th, 2001 • Biodelivery Sciences International Inc • Blank checks • New Jersey
AGREEMENT
Stock Purchase Agreement • April 29th, 2002 • Biodelivery Sciences International Inc • Blank checks • Florida
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • June 3rd, 2005 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York

This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, by and between the Purchaser and the Company (as amended, modified or supplemented from time to time, the “Securities Purchase Agreement”), and pursuant to the Note and the Warrants referred to therein.

FORM OF
Underwriting Agreement • November 7th, 2001 • Biodelivery Sciences International Inc • Blank checks • New York
1 EXHIBIT 10.1 AGREEMENT OF MERGER AND PLAN OF REORGANIZATION BY AND BETWEEN BIODELIVERY SCIENCES INTERNATIONAL, INC.
Merger Agreement • August 20th, 2001 • Biodelivery Sciences International Inc • Blank checks • Delaware
WITNESSETH:
Stock Purchase Agreement • January 25th, 2001 • Biodelivery Sciences International Inc • Blank checks • Delaware
AutoNDA by SimpleDocs
FIRST AMENDMENT TO SUB-LICENSE AGREEMENT BETWEEN BIODELIVERY SCIENCES INTERNATIONAL, INC. AND BIORAL NUTRIENT DELIVERY, LLC
Sub-License Agreement • November 19th, 2003 • Biodelivery Sciences International Inc • Pharmaceutical preparations
STOCK PLEDGE AGREEMENT
Stock Pledge Agreement • February 25th, 2005 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York

This Stock Pledge Agreement (this “Agreement”), dated as of February 22, 2005, among Laurus Master Fund, Ltd. (the “Pledgee”), BioDelivery Sciences International, Inc., a Delaware corporation (the “Company”), and each of the other undersigned parties (other than the Pledgee) (the Company and each such other undersigned party, a “Pledgor” and collectively, the “Pledgors”).

RECITALS:
Employment Agreement • August 20th, 2001 • Biodelivery Sciences International Inc • Blank checks • Indiana
Contract
Warrant Agreement • June 3rd, 2005 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York

THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRANT UNDER SAID ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO BIODELIVERY SCIENCES INTERNATIONAL, INC. THAT SUCH REGISTRATION IS NOT REQUIRED.

Contract
Secured Convertible Term Note • June 3rd, 2005 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York

THIS NOTE AND THE COMMON SHARES ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. THIS NOTE AND THE COMMON SHARES ISSUABLE UPON CONVERSION OF THIS NOTE MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS NOTE UNDER SAID ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO BIODELIVERY SCIENCES INTERNATIONAL, INC. THAT SUCH REGISTRATION IS NOT REQUIRED.

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • March 16th, 2011 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York

This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of March 11, 2011, is made by and among BioDelivery Sciences International, Inc., a Delaware corporation (the “Company”), and the Purchasers listed on Exhibit A hereto, together with their permitted transferees (each, a “Purchaser” and collectively, the “Purchasers”).

SECURITIES PURCHASE AGREEMENT LAURUS MASTER FUND, LTD. and BIODELIVERY SCIENCES INTERNATIONAL, INC. Dated: May 31, 2005
Securities Purchase Agreement • June 3rd, 2005 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York

THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of May 31st, 2005, by and between BIODELIVERY SCIENCES INTERNATIONAL, INC., a Delaware corporation (the “Company”), and LAURUS MASTER FUND, LTD., a Cayman Islands company (the “Purchaser”).

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • May 17th, 2018 • Biodelivery Sciences International Inc • Pharmaceutical preparations

REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of May 17, 2018, by and among Biodelivery Sciences International, Inc., a Delaware corporation, with headquarters located at 4131 Parklane Avenue, Suite 225, Raleigh, NC 27612 (the “Company”), and the Lead Investor (as defined below) (each a “Investor” and collectively the “Investors”, provided that, if the context requires, references to “Investors” shall be deemed to be references to “Investor”).

Contract
Warrant Agreement • January 4th, 2007 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York

THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRANT UNDER SAID ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO BIODELIVERY SCIENCES INTERNATIONAL, INC. THAT SUCH REGISTRATION IS NOT REQUIRED.

EMPLOYMENT AGREEMENT
Employment Agreement • February 23rd, 2007 • Biodelivery Sciences International Inc • Pharmaceutical preparations • Delaware

This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective as of February 22, 2007 by and between Raphael J. Mannino (“Employee”) and BioDelivery Sciences International, Inc. (the “Company”).

AND
Underwriter's Option Agreement for Units • May 23rd, 2002 • Biodelivery Sciences International Inc • Blank checks • New York
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!